Altido Therapeutics is a startup based in the United States.
Altido Therapeutics is a startup based in the United States.
Altido Therapeutics is a clinical-stage biotech company developing a novel CAR-TEAM T cell-based immunotherapy platform to treat difficult-to-treat solid tumors such as glioblastoma by targeting tumors with genetically engineered CAR-T cells that secrete T-cell engaging molecules.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.